NFKB1 and ischemic stroke: LINGO-1 shRNA could ameliorate neurological deficits, reduce brain infarct volume and damage to cerebral cortical neurons in vivo ischemic stroke model, alleviate apoptosis and promote cell proliferation in vitro ischemic stroke model via the NF-κB and JAK2/STAT3 pathway.